Endothelial Progenitor Cells Enter the Aging Arena.
Age is a significant risk factor for the development of vascular diseases, such as atherosclerosis. Although pharmacological treatments, including statins and anti-hypertensive drugs, have improved the prognosis for patients with cardiovascular disease, it remains a leading cause of mortality in tho...
Main Authors: | Kate eWilliamson, Sally eStringer, Yvonne eAlexander |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-02-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphys.2012.00030/full |
Similar Items
-
Improved placental vascular repair in a rat preeclampsia model by implantation of endothelial progenitor cells treated with platelet microparticles
by: Zhenya Fang, et al.
Published: (2020-10-01) -
Editorial: Regulation of Vascular Function by Circulating Blood
by: Joseph M. Rifkind, et al.
Published: (2019-05-01) -
Rhynchophylline Attenuates Senescence of Endothelial Progenitor Cells by Enhancing Autophagy
by: Lin Lin, et al.
Published: (2020-01-01) -
Carvacrol Improves Vascular Function in Hypertensive Animals by Modulating Endothelial Progenitor Cells
by: Tays Amanda Felisberto Gonçalves, et al.
Published: (2023-07-01) -
Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches
by: Anne-Christine Peyter, et al.
Published: (2021-06-01)